Human(ized) monoclonal antibodies in atopic patients: state of the art
Asthma is an important chronic disease affecting a lot of people worldwide. Treatment options for asthma like biological agents are being developed more frequently nowadays. Despite a lot of treatment options, some patients still remain symptomatic. As more and more practitioners choose treatment...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2020/07/27
|
| In: |
Central European journal of immunology
Year: 2020, Jahrgang: 45, Heft: 2, Pages: 195-201 |
| ISSN: | 1644-4124 |
| DOI: | 10.5114/ceji.2020.97909 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.5114/ceji.2020.97909 Verlag, lizenzpflichtig, Volltext: https://www.termedia.pl/Human-ized-monoclonal-antibodies-in-atopic-patients-state-of-the-art,10,41515,0,1.html 
|
| Verfasserangaben: | Arzu Didem Yalcin, Kevser Onbasi, Rusen Uzun, Felix Herth, Philipp Albert Schnabel |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1733242694 | ||
| 003 | DE-627 | ||
| 005 | 20230427150628.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200917s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.5114/ceji.2020.97909 |2 doi | |
| 035 | |a (DE-627)1733242694 | ||
| 035 | |a (DE-599)KXP1733242694 | ||
| 035 | |a (OCoLC)1341360526 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Yalcin, Arzu Didem |e VerfasserIn |0 (DE-588)1217820205 |0 (DE-627)1733243291 |4 aut | |
| 245 | 1 | 0 | |a Human(ized) monoclonal antibodies in atopic patients |b state of the art |c Arzu Didem Yalcin, Kevser Onbasi, Rusen Uzun, Felix Herth, Philipp Albert Schnabel |
| 264 | 1 | |c 2020/07/27 | |
| 300 | |a 7 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 17.09.2020 | ||
| 520 | |a Asthma is an important chronic disease affecting a lot of people worldwide. Treatment options for asthma like biological agents are being developed more frequently nowadays. Despite a lot of treatment options, some patients still remain symptomatic. As more and more practitioners choose treatment... | ||
| 700 | 1 | |a Onbasi, Kevser |e VerfasserIn |4 aut | |
| 700 | 1 | |a Uzun, Rusen |e VerfasserIn |4 aut | |
| 700 | 1 | |a Herth, Felix |e VerfasserIn |0 (DE-588)1016095236 |0 (DE-627)705477568 |0 (DE-576)351509925 |4 aut | |
| 700 | 1 | |a Schnabel, Philipp Albert |d 1953-2021 |e VerfasserIn |0 (DE-588)102254960X |0 (DE-627)717000087 |0 (DE-576)16982750X |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Central European journal of immunology |d Poznań : Termedia Wydawn., 2002 |g 45(2020), 2, Seite 195-201 |h Online-Ressource |w (DE-627)511229127 |w (DE-600)2233185-2 |w (DE-576)347276598 |x 1644-4124 |7 nnas |a Human(ized) monoclonal antibodies in atopic patients state of the art |
| 773 | 1 | 8 | |g volume:45 |g year:2020 |g number:2 |g pages:195-201 |g extent:7 |a Human(ized) monoclonal antibodies in atopic patients state of the art |
| 856 | 4 | 0 | |u https://doi.org/10.5114/ceji.2020.97909 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.termedia.pl/Human-ized-monoclonal-antibodies-in-atopic-patients-state-of-the-art,10,41515,0,1.html |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20200917 | ||
| 993 | |a Article | ||
| 994 | |a 2020 | ||
| 998 | |g 102254960X |a Schnabel, Philipp Albert |m 102254960X:Schnabel, Philipp Albert |p 7 | ||
| 998 | |g 1016095236 |a Herth, Felix |m 1016095236:Herth, Felix |d 50000 |d 910000 |d 950000 |d 950900 |e 50000PH1016095236 |e 910000PH1016095236 |e 950000PH1016095236 |e 950900PH1016095236 |k 0/50000/ |k 0/910000/ |k 1/910000/950000/ |k 2/910000/950000/950900/ |p 6 | ||
| 999 | |a KXP-PPN1733242694 |e 375752151X | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"title":[{"title":"Human(ized) monoclonal antibodies in atopic patients","title_sort":"Human(ized) monoclonal antibodies in atopic patients","subtitle":"state of the art"}],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Gesehen am 17.09.2020"],"origin":[{"dateIssuedDisp":"2020/07/27","dateIssuedKey":"2020"}],"relHost":[{"title":[{"title":"Central European journal of immunology","title_sort":"Central European journal of immunology"}],"note":["Gesehen am 14.02.14"],"type":{"media":"Online-Ressource","bibl":"periodical"},"language":["eng","pol"],"origin":[{"dateIssuedKey":"2002","publisherPlace":"Poznań","dateIssuedDisp":"2002-","publisher":"Termedia Wydawn."}],"disp":"Human(ized) monoclonal antibodies in atopic patients state of the artCentral European journal of immunology","recId":"511229127","physDesc":[{"extent":"Online-Ressource"}],"part":{"issue":"2","text":"45(2020), 2, Seite 195-201","extent":"7","pages":"195-201","volume":"45","year":"2020"},"id":{"eki":["511229127"],"issn":["1644-4124"],"zdb":["2233185-2"]},"pubHistory":["Nachgewiesen 27.2002 -"],"name":{"displayForm":["Polish Society for Immunology"]},"corporate":[{"role":"isb","display":"Polskie Towarzystwo Immunologiczne"}]}],"person":[{"role":"aut","given":"Arzu Didem","family":"Yalcin","display":"Yalcin, Arzu Didem"},{"display":"Onbasi, Kevser","given":"Kevser","role":"aut","family":"Onbasi"},{"given":"Rusen","role":"aut","family":"Uzun","display":"Uzun, Rusen"},{"given":"Felix","role":"aut","family":"Herth","display":"Herth, Felix"},{"display":"Schnabel, Philipp Albert","family":"Schnabel","given":"Philipp Albert","role":"aut"}],"recId":"1733242694","physDesc":[{"extent":"7 S."}],"id":{"eki":["1733242694"],"doi":["10.5114/ceji.2020.97909"]},"name":{"displayForm":["Arzu Didem Yalcin, Kevser Onbasi, Rusen Uzun, Felix Herth, Philipp Albert Schnabel"]}} | ||
| SRT | |a YALCINARZUHUMANIZEDM2020 | ||